description
Powered by Eupheria Biotech
product line
MISSION®
form
lyophilized powder
esiRNA cDNA target sequence
GGACTTGGAAGAAGCTGTGCAGATGCTGGTAGAGGGAAAGGAAGAGGGGCCTGCAGCCTGGGAGGGCCCCAACCAGGACCTGCCCAGACGCCTCAGAGGCCCCCAAAAGGATGAGCTGAAGTCCTTCATCCTGCAGAAGTACATGATGGTGGATAGCGCAGAGGATCAGAAGATTCACCGGCCCATGGCTCCCAAGGAGGCCCCCAAGAAGCTGATCCGATACATCGACAACCAGGTAGTGAGCACCAAAGGGGAGCGATTCAAAGATGTGCGGAACCCTGAGGCCGAGGAGATGAAGGCCACATACATCAACCTCAAGCCAGCCAGAAAGTACCGCTTCCATTGAGGCACTCGCCGGACTCTGCCCGAGCCTTCTAGGCTCAGATCCCAGAGGGATGCAGGAGCCCTATACCCCTACACAGGGGCCCCCTAACTCCTGTCCCCCTTC
Ensembl | human accession no.
NCBI accession no.
shipped in
ambient
storage temp.
−20°C
Quality Level
General description
MISSION® esiRNA are endoribonuclease prepared siRNA. They are a heterogeneous mixture of siRNA that all target the same mRNA sequence. These multiple silencing triggers lead to highly-specific and effective gene silencing.
For additional details as well as to view all available esiRNA options, please visit SigmaAldrich.com/esiRNA.
For additional details as well as to view all available esiRNA options, please visit SigmaAldrich.com/esiRNA.
Legal Information
MISSION is a registered trademark of Merck KGaA, Darmstadt, Germany
存储类别
10 - Combustible liquids
flash_point_f
Not applicable
flash_point_c
Not applicable
法规信息
新产品
此项目有
Xianpu Zhang et al.
Molecular medicine reports, 18(1), 855-863 (2018-05-31)
Treatment with doxorubicin (DOX), which is an effective anticancer agent, is limited by cardiotoxicity. CUE domain‑containing 2 (CUEDC2) serves a role in numerous cellular processes. The present study aimed to elucidate the potential function of CUEDC2 in DOX‑induced cardiotoxicity. Cell
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持